Similarly, the impact of inflammatory cytokines in the negative regulation of LPL activity in T2D should be studied in detail because inflammation could be manipulated to alleviate LPL dysfunction and lipid disorders. This evidence concerns the gene LPL and type 2 diabetes mellitus.